Loading data
BMRNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.22 bn USD | 2.85 bn USD | 2.42 bn USD | 2.1 bn USD | 1.85 bn USD |
| Cost of revenue | 717.44 m USD | 580.24 m USD | 532.06 m USD | 503.02 m USD | 470.52 m USD |
| Research and development expense | 921.93 m USD | 747.18 m USD | 746.77 m USD | 649.61 m USD | 628.79 m USD |
| Selling, general and administrative expense | 1.15 bn USD | 1.01 bn USD | 892.41 m USD | 823.24 m USD | 759.38 m USD |
| Operating profit | 409.48 m USD | 484.21 m USD | 185.77 m USD | 160.97 m USD | -82.34 m USD |
| Interest expense | — | — | 17.34 m USD | 15.97 m USD | 15.34 m USD |
| Profit before tax | 482.48 m USD | 541.76 m USD | 188.56 m USD | 149.58 m USD | -75.35 m USD |
| Income tax expense | 133.58 m USD | 114.9 m USD | 20.92 m USD | 8.02 m USD | -11.27 m USD |
| Net income (reported basis) | 348.9 m USD | 426.9 m USD | 167.6 m USD | 141.6 m USD | -64.1 m USD |
| Net income attributable to common shareholders | 348.9 m USD | 426.86 m USD | 167.65 m USD | 141.56 m USD | -64.08 m USD |
| Basic earnings per share | 1.82 USD/share | 2.25 USD/share | 0.89 USD/share | 0.76 USD/share | -0.35 USD/share |
| Diluted earnings per share | 1.8 USD/share | 2.21 USD/share | 0.87 USD/share | 0.75 USD/share | -0.35 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.